sufentanil
Showing 1 - 25 of 96
Intraoperative Hypotension Trial (Sufentanil, Remifentanil)
Not yet recruiting
- Intraoperative Hypotension
- Sufentanil
- Remifentanil
- (no location specified)
Oct 13, 2023
Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- Oxycodone
- Sufentanil
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023
Analgesia, Labor Pain Trial in Wuhan (Hydromorphone, Sufentanil, Ropivacaine)
Not yet recruiting
- Analgesia
- Labor Pain
- Hydromorphone
- +2 more
-
Wuhan, Hubei, ChinaMaternal and Child Health Hospital of Hubei Province
Sep 7, 2023
Acute Respiratory Distress Syndrome Trial (Nalbuphine, Sufentanil)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Nalbuphine
- Sufentanil
- (no location specified)
Sep 7, 2023
Anesthesia, Dexmedetomidine, Hemodynamics Trial in Nîmes (Dexmedetomidine, Sufentanil)
Not yet recruiting
- Anesthesia
- +3 more
- Dexmedetomidine
- Sufentanil
-
Nîmes, FranceCHU de Nîmes
Oct 9, 2023
Gastrointestinal Surgery Trial in XIan (sufentanil + nalbuphine, Sufentanil, hydromorphone + nalbuphine)
Completed
- Gastrointestinal Surgery
- sufentanil + nalbuphine
- +2 more
-
XIan, Shanxi, ChinaYANLI
Oct 11, 2022
Analgesia, Labor Pain Trial in Wuhan (Hydromorphone, Sufentanil, Ropivacaine)
Completed
- Analgesia
- Labor Pain
- Hydromorphone
- +2 more
-
Wuhan, Hubei, ChinaMaternal and Child Health Hospital of Hubei Province
Jun 4, 2023
Postoperative Recovery Trial in Fuzhou (lidocaine, 0.9% saline, Propofol)
Not yet recruiting
- Postoperative Recovery
- lidocaine
- +3 more
-
Fuzhou, Fujian, ChinaFujian provincial hospital
Feb 20, 2023
Healthy Trial in Dallas (Sufentanil, Placebo)
Recruiting
- Healthy
- Sufentanil
- Placebo
-
Dallas, TexasInstitute for Exercise and Environmental Medicine
Mar 23, 2022
Knee Arthroscopy Trial in Cleveland (Sufentanil, Fentanyl)
Recruiting
- Knee Arthroscopy
- Sufentanil
- Fentanyl
-
Cleveland, OhioCleveland Clinic Fairview Hospital
Mar 23, 2022
Pain Trial in Phoenix (sufentanil)
Recruiting
- Pain
- sufentanil
-
Phoenix, ArizonaThe CORE Institute Specialty Hospital
Mar 29, 2022
Rapid Sequence Induction Trial in Corbeil-essonnes Cedex (Remifentanil, Sufentanil, Placebo)
Not yet recruiting
- Rapid Sequence Induction
- Remifentanil
- +2 more
-
Corbeil-essonnes Cedex, FranceCentre Hospitalier Sud Francilien
Sep 14, 2022
Oxycodone Trial (Oxycodone 1mg/kg, Oxycodone 1.5mg/kg, Sufentanil)
Not yet recruiting
- Oxycodone
- Oxycodone 1mg/kg
- +2 more
- (no location specified)
Feb 15, 2023
Pain Trial in Seoul (ANI (Analgesia/Nociception Index) monitoring, standard monitoring, Sufentanil)
Recruiting
- Pain
- ANI (Analgesia/Nociception Index) monitoring
- +2 more
-
Seoul, Korea, Republic ofSeoul national university hospital
Jan 5, 2023
Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- Esketamine
- Sufentanil
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023
Scoliosis Correction, Postoperative Analgesia, S-ketamine Trial in Beijing (S-ketamine, Dexmedetomidine, Sufentanil)
Recruiting
- Scoliosis Correction
- +4 more
- S-ketamine
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Apr 19, 2022
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine, Dexmedetomidine, Sufentanil)
Active, not recruiting
- Scoliosis Correction
- +4 more
- Esketamine
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital
Feb 7, 2023
Opioid Use, Unspecified, S-ketamine Trial in Nanjing (S-ketamine, Sufentanil)
Recruiting
- Opioid Use, Unspecified
- S-ketamine
- S-ketamine
- Sufentanil
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jul 19, 2022
Analgesia Trial in Beirut (sufentanil, meperidine, Bupivacaine)
Recruiting
- Analgesia
- sufentanil
- +2 more
-
Beirut, LebanonMakassed General Hospital
Jul 28, 2021
Hemodynamic Instability Trial in Seoul (REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for
Recruiting
- Hemodynamic Instability
- REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 8, 2022